
    
      Patients are enrolled and randomized into 3 groups. Start of therapy is determined as the
      beginning of cardiopulmonary bypass. Group A: Therapy with computer-based algorithm and
      measurement of blood glucose every 30 min. Group B: Measurement of blood glucose every 15 min
      using the identical computer-based algorithm. Group C: Conventional therapy using a fixed
      insulin dosing scheme. End of therapy is defined as discharge from ICU.
    
  